FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2315750498> ?p ?o ?g. }

• W2315750498 abstract "Angiotensin-(1-7) [Ang-(1-7)] is an endogenous seven-amino acid peptide hormone of the renin-angiotensin system with anti-proliferative properties. We previously showed that Ang-(1-7) significantly inhibited the growth of non-small cell lung adenocarcinoma in a xenograft mouse model in association with a reduction in angiogenesis. In a recently completed Phase I clinical trial conducted in the Wake Forest University Comprehensive Cancer Center, we reported that Ang-(1-7) significantly reduced the pro-angiogenic factor placental growth factor (PlGF) in four patients who had stable disease for greater than 3 months, suggesting that Ang-(1-7) is a novel anti-angiogenic drug for the treatment of cancer. In this study, BT-474 human epidermal growth factor receptor 2 (HER2) over-expressed, estrogen receptor (ER) positive breast cancer cells or ZR-75-1 ER positive breast cancer cells were injected into mammary fat pads of athymic mice and treated with Ang-(1-7), to determine the effect of the drug on breast cancer. After the tumors grew to 100-200 mm 3 , mice were treated with either saline or 24 µg/kg/h Ang-(1-7) for 18 days. Treatment with Ang-(1-7) reduced tumor volume (68.2% in BT-474 tumors and 77.0% in ZR-75-1 tumors) and tumor weight (38.9% in BT-474 tumors and 50% in ZR-75-1 tumors), indicating that the heptapeptide inhibits breast tumor growth. Vessel density was also decreased 50% by the heptapeptide, demonstrating that Ang-(1-7) reduced angiogenesis in breast tumors. Tumoral fibrosis, measured by picrosirius red collagen staining, was attenuated in Ang-(1-7)-treated breast tumors. The heptapeptide reduced interstitial fibrosis from 4.91 ± 0.96%/field to 1.2 ± 0.2 in BT474 tumors and from 23.3 ± 2.4%/field to 8.3 ± 0.8 in ZR-75-1 tumors, in association with a 66% reduction in collagen I deposition. Treatment with Ang-(1-7) also reduced perivascular fibrosis in BT-474 tumors, from 49.3 ± 3.2% fibrosis/vessel to 13.4 ± 2.2% fibrosis/vessel. Ang-(1-7) markedly attenuated the in vitro growth of fibroblasts isolated from orthotopic breast tumors. Treatment of tumoral fibroblasts with Ang-(1-7) reduced fibronectin protein by 40%, in association with a 50% decrease in transforming growth factor-β (TGF-β). Ang-(1-7) also caused a 2-fold increase in the mitogen-activated protein (MAP) kinase phosphatase DUSP1, with an associated 50% decrease in MAP kinase ERK1 and ERK2 activities, suggesting that the heptapeptide increases DUSP1 to reduce MAP kinase signaling. This is the first report that Ang-(1-7) targets the tumor microenvironment, by inhibiting the growth of tumor-associated fibroblasts to reduce fibrosis. Collectively, these results suggest that Ang-(1-7) may serve as a first-in-class chemotherapeutic agent for breast cancer, targeting the tumor microenvironment through a reduction in angiogenesis and a decrease in tumor fibrosis. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 2273." @default.
• W2315750498 created "2016-06-24" @default.
• W2315750498 creator A5025967603 @default.
• W2315750498 creator A5057203129 @default.
• W2315750498 creator A5064049204 @default.
• W2315750498 date "2010-04-15" @default.
• W2315750498 modified "2023-09-27" @default.
• W2315750498 title "Abstract 2273: Angiotensin-(1-7) reduces angiogenesis and fibrosis in orthotopic breast cancer" @default.
• W2315750498 doi "https://doi.org/10.1158/1538-7445.am10-2273" @default.
• W2315750498 hasPublicationYear "2010" @default.
• W2315750498 type Work @default.
• W2315750498 sameAs 2315750498 @default.
• W2315750498 citedByCount "0" @default.
• W2315750498 crossrefType "proceedings-article" @default.
• W2315750498 hasAuthorship W2315750498A5025967603 @default.
• W2315750498 hasAuthorship W2315750498A5057203129 @default.
• W2315750498 hasAuthorship W2315750498A5064049204 @default.
• W2315750498 hasConcept C121608353 @default.
• W2315750498 hasConcept C126322002 @default.
• W2315750498 hasConcept C134018914 @default.
• W2315750498 hasConcept C167734588 @default.
• W2315750498 hasConcept C170493617 @default.
• W2315750498 hasConcept C2776056115 @default.
• W2315750498 hasConcept C2776187077 @default.
• W2315750498 hasConcept C2776256026 @default.
• W2315750498 hasConcept C2777025900 @default.
• W2315750498 hasConcept C2777164284 @default.
• W2315750498 hasConcept C2780288358 @default.
• W2315750498 hasConcept C2780394083 @default.
• W2315750498 hasConcept C2908929049 @default.
• W2315750498 hasConcept C502942594 @default.
• W2315750498 hasConcept C530470458 @default.
• W2315750498 hasConcept C71924100 @default.
• W2315750498 hasConcept C84606932 @default.
• W2315750498 hasConceptScore W2315750498C121608353 @default.
• W2315750498 hasConceptScore W2315750498C126322002 @default.
• W2315750498 hasConceptScore W2315750498C134018914 @default.
• W2315750498 hasConceptScore W2315750498C167734588 @default.
• W2315750498 hasConceptScore W2315750498C170493617 @default.
• W2315750498 hasConceptScore W2315750498C2776056115 @default.
• W2315750498 hasConceptScore W2315750498C2776187077 @default.
• W2315750498 hasConceptScore W2315750498C2776256026 @default.
• W2315750498 hasConceptScore W2315750498C2777025900 @default.
• W2315750498 hasConceptScore W2315750498C2777164284 @default.
• W2315750498 hasConceptScore W2315750498C2780288358 @default.
• W2315750498 hasConceptScore W2315750498C2780394083 @default.
• W2315750498 hasConceptScore W2315750498C2908929049 @default.
• W2315750498 hasConceptScore W2315750498C502942594 @default.
• W2315750498 hasConceptScore W2315750498C530470458 @default.
• W2315750498 hasConceptScore W2315750498C71924100 @default.
• W2315750498 hasConceptScore W2315750498C84606932 @default.
• W2315750498 hasLocation W23157504981 @default.
• W2315750498 hasOpenAccess W2315750498 @default.
• W2315750498 hasPrimaryLocation W23157504981 @default.
• W2315750498 hasRelatedWork W1641553514 @default.
• W2315750498 hasRelatedWork W1911520287 @default.
• W2315750498 hasRelatedWork W1969334417 @default.
• W2315750498 hasRelatedWork W1982903140 @default.
• W2315750498 hasRelatedWork W1995582677 @default.
• W2315750498 hasRelatedWork W2024149631 @default.
• W2315750498 hasRelatedWork W2025251060 @default.
• W2315750498 hasRelatedWork W2098073308 @default.
• W2315750498 hasRelatedWork W2107950465 @default.
• W2315750498 hasRelatedWork W2114435925 @default.
• W2315750498 hasRelatedWork W2144727447 @default.
• W2315750498 hasRelatedWork W2150497617 @default.
• W2315750498 hasRelatedWork W2171829664 @default.
• W2315750498 hasRelatedWork W2213811175 @default.
• W2315750498 hasRelatedWork W2320802927 @default.
• W2315750498 hasRelatedWork W2325703190 @default.
• W2315750498 hasRelatedWork W2331669180 @default.
• W2315750498 hasRelatedWork W2787422742 @default.
• W2315750498 hasRelatedWork W2801937622 @default.
• W2315750498 hasRelatedWork W3042601069 @default.
• W2315750498 isParatext "false" @default.
• W2315750498 isRetracted "false" @default.
• W2315750498 magId "2315750498" @default.
• W2315750498 workType "article" @default.